Achilles Therapeutics plc

NasdaqCM:ACHL 주식 보고서

시가총액: US$44.0m

Achilles Therapeutics 관리

관리 기준 확인 2/4

Achilles Therapeutics CEO는 Iraj Ali, Jan2018 에 임명되었습니다 의 임기는 6.83 년입니다. 총 연간 보상은 $ 1.70M, 27.3% 로 구성됩니다. 27.3% 급여 및 72.7% 보너스(회사 주식 및 옵션 포함). 는 $ 1.19M 가치에 해당하는 회사 주식의 2.71% 직접 소유합니다. 1.19M. 경영진과 이사회의 평균 재임 기간은 각각 5.4 년과 4.5 년입니다.

주요 정보

Iraj Ali

최고 경영자

US$1.7m

총 보상

CEO 급여 비율27.3%
CEO 임기6.8yrs
CEO 소유권2.7%
경영진 평균 재임 기간5.4yrs
이사회 평균 재임 기간4.5yrs

최근 관리 업데이트

Recent updates

Is Achilles Therapeutics (NASDAQ:ACHL) In A Good Position To Invest In Growth?

Sep 20
Is Achilles Therapeutics (NASDAQ:ACHL) In A Good Position To Invest In Growth?

Is Achilles Therapeutics (NASDAQ:ACHL) In A Good Position To Deliver On Growth Plans?

Feb 26
Is Achilles Therapeutics (NASDAQ:ACHL) In A Good Position To Deliver On Growth Plans?

Here's Why We're Watching Achilles Therapeutics' (NASDAQ:ACHL) Cash Burn Situation

Nov 13
Here's Why We're Watching Achilles Therapeutics' (NASDAQ:ACHL) Cash Burn Situation

Here's Why We're Watching Achilles Therapeutics' (NASDAQ:ACHL) Cash Burn Situation

Jul 19
Here's Why We're Watching Achilles Therapeutics' (NASDAQ:ACHL) Cash Burn Situation

Is Achilles Therapeutics (NASDAQ:ACHL) In A Good Position To Deliver On Growth Plans?

Mar 11
Is Achilles Therapeutics (NASDAQ:ACHL) In A Good Position To Deliver On Growth Plans?

Here's Why We're Watching Achilles Therapeutics' (NASDAQ:ACHL) Cash Burn Situation

Nov 18
Here's Why We're Watching Achilles Therapeutics' (NASDAQ:ACHL) Cash Burn Situation

Achilles-led group gets €4M funding for personalized cell therapy manufacturing

Jul 21

Is Achilles Therapeutics (NASDAQ:ACHL) In A Good Position To Invest In Growth?

Apr 13
Is Achilles Therapeutics (NASDAQ:ACHL) In A Good Position To Invest In Growth?

Achilles Therapeutics (NASDAQ:ACHL) Is In A Good Position To Deliver On Growth Plans

Dec 27
Achilles Therapeutics (NASDAQ:ACHL) Is In A Good Position To Deliver On Growth Plans

Here's Why We're Not Too Worried About Achilles Therapeutics' (NASDAQ:ACHL) Cash Burn Situation

Sep 09
Here's Why We're Not Too Worried About Achilles Therapeutics' (NASDAQ:ACHL) Cash Burn Situation

CEO 보상 분석

Iraj Ali 의 보수는 Achilles Therapeutics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

-US$67m

Jun 30 2024n/an/a

-US$64m

Mar 31 2024n/an/a

-US$64m

Dec 31 2023US$2mUS$463k

-US$70m

보상 대 시장: Iraj 의 총 보상 ($USD 1.70M )은 US 시장( $USD 646.00K ).

보상과 수익: Iraj 의 보상을 회사 성과와 비교하기에는 데이터가 부족합니다.


CEO

Iraj Ali (49 yo)

6.8yrs

테뉴어

US$1,698,000

보상

Dr. Iraj Ali, Ph.D. serves as Chief Executive Officer at Achilles Therapeutics Plc since December 10, 2018 and served as its Interim Chief Executive Officer since January 2018 until December 10, 2018. Dr....


리더십 팀

이름위치테뉴어보상소유권
Iraj Ali
CEO & Director6.8yrsUS$1.70m2.71%
$ 1.2m
Sergio Quezada
Founder & Chief Scientific Officer8.8yrs데이터 없음1.12%
$ 494.9k
Robert Coutts
Chief Financial Officer4yrs데이터 없음0.66%
$ 288.9k
Mark Lowdell
Founder & Member of Scientific Advisory Board8.8yrs데이터 없음데이터 없음
Charles Swanton
Founder & Member of Scientific Advisory Board8.8yrs데이터 없음데이터 없음
Lee Stern
Vice President of Investor Relations & External Communications3.9yrs데이터 없음데이터 없음
Daniel Carey Hood
General Counsel & Company Secretary2yrs데이터 없음데이터 없음
Julia Wilson
Head of Communicationsno data데이터 없음데이터 없음
Tariq Ahmed
Executive Vice President of Peopleno data데이터 없음데이터 없음
Edward Samuel
Executive Vice President of Technical Operationsno data데이터 없음데이터 없음
Shree Patel
Executive Vice President of Supply Operationsno data데이터 없음데이터 없음
James A. Taylor
Chief Business Officer2.8yrs데이터 없음데이터 없음

5.4yrs

평균 재임 기간

50.5yo

평균 연령

경험이 풍부한 관리: ACHL 의 관리팀은 노련하고 경험 (평균 재직 기간 5.4 년)입니다.


이사회 구성원

이름위치테뉴어보상소유권
Iraj Ali
CEO & Director8.7yrsUS$1.70m2.71%
$ 1.2m
Mark Lowdell
Founder & Member of Scientific Advisory Boardless than a year데이터 없음데이터 없음
Charles Swanton
Founder & Member of Scientific Advisory Boardless than a year데이터 없음데이터 없음
Edwin Moses
Independent Chairman of the Board5.9yrsUS$379.00k0.55%
$ 242.4k
Carsten Boess
Independent Non-Executive Director4.6yrsUS$176.00k0%
$ 0
Markwin Velders
Member of Scientific Advisory Board3.5yrs데이터 없음데이터 없음
Scott Antonia
Member of Scientific Advisory Board4.5yrs데이터 없음데이터 없음
Michael Giordano
Independent Non-Executive Director6.2yrsUS$189.00k0.11%
$ 50.0k
Karl Peggs
Founder & Member of Scientific Advisory Boardless than a year데이터 없음1.36%
$ 600.2k
Elizabeth Jaffee
Member of Scientific Advisory Board4.5yrs데이터 없음데이터 없음
Christopher Klebanoff
Member of Scientific Advisory Board4.5yrs데이터 없음데이터 없음
Alena Gros
Member of Scientific Advisory Board2.8yrs데이터 없음데이터 없음

4.5yrs

평균 재임 기간

58yo

평균 연령

경험이 풍부한 이사회: ACHL 의 이사회경험(평균 재직 기간 4.5 년)으로 간주됩니다.